Annual accounts receivable:
$4.72M+$2.97M(+169.67%)Summary
- As of today (September 15, 2025), BBIO annual accounts receivable is $4.72 million, with the most recent change of +$2.97 million (+169.67%) on December 31, 2024.
- During the last 3 years, BBIO annual accounts receivable has fallen by -$15.03 million (-76.09%).
- BBIO annual accounts receivable is now -76.09% below its all-time high of $19.75 million, reached on December 31, 2021.
Performance
BBIO Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$76.87M-$38.40M(-33.31%)Summary
- As of today (September 15, 2025), BBIO quarterly accounts receivable is $76.87 million, with the most recent change of -$38.40 million (-33.31%) on June 30, 2025.
- Over the past year, BBIO quarterly accounts receivable has increased by +$76.21 million (+11546.67%).
- BBIO quarterly accounts receivable is now -67.36% below its all-time high of $235.49 million, reached on March 31, 2024.
Performance
BBIO Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BBIO Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +169.7% | +10000.0% |
| 3 y3 years | -76.1% | +236.8% |
| 5 y5 years | - | - |
BBIO Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.1% | +169.7% | -67.4% | >+9999.0% |
| 5 y | 5-year | -76.1% | >+9999.0% | -67.4% | >+9999.0% |
| alltime | all time | -76.1% | >+9999.0% | -67.4% | >+9999.0% |
BBIO Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $76.87M(-33.3%) |
| Mar 2025 | - | $115.27M(+2341.0%) |
| Dec 2024 | $4.72M(+169.7%) | $4.72M(+887.9%) |
| Sep 2024 | - | $478.00K(-27.6%) |
| Jun 2024 | - | $660.00K(-99.7%) |
| Mar 2024 | - | $235.49M(>+9900.0%) |
| Dec 2023 | $1.75M(-89.7%) | $1.75M(-66.1%) |
| Sep 2023 | - | $5.17M(-40.0%) |
| Jun 2023 | - | $8.61M(-20.0%) |
| Mar 2023 | - | $10.76M(-37.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $17.08M(-13.5%) | $17.08M(-30.5%) |
| Sep 2022 | - | $24.58M(+7.7%) |
| Jun 2022 | - | $22.82M(+107.8%) |
| Mar 2022 | - | $10.98M(-44.4%) |
| Dec 2021 | $19.75M(>+9900.0%) | $19.75M(+141.7%) |
| Sep 2021 | - | $8.17M(-19.7%) |
| Jun 2021 | - | $10.18M(+2102.4%) |
| Mar 2021 | - | $462.00K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00(-100.0%) |
| Sep 2020 | - | $8.00M |
FAQ
- What is BridgeBio Pharma, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual accounts receivable year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly accounts receivable year-on-year change?
What is BridgeBio Pharma, Inc. annual accounts receivable?
The current annual accounts receivable of BBIO is $4.72M
What is the all time high annual accounts receivable for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual accounts receivable is $19.75M
What is BridgeBio Pharma, Inc. annual accounts receivable year-on-year change?
Over the past year, BBIO annual accounts receivable has changed by +$2.97M (+169.67%)
What is BridgeBio Pharma, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of BBIO is $76.87M
What is the all time high quarterly accounts receivable for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly accounts receivable is $235.49M
What is BridgeBio Pharma, Inc. quarterly accounts receivable year-on-year change?
Over the past year, BBIO quarterly accounts receivable has changed by +$76.21M (+11546.67%)